Diversion Quarterly Q3 2022

Bluesight® is pulling data from its ControlCheck™ platform on a quarterly basis to provide insight into the types of diversions and investigations that may be occurring in hospital pharmacies. The following information is as of September 30th, 2022. Data was pulled from health systems across the United States.

Key Takeaways:

Technology solutions, such as ControlCheck, can flag potential diversion an average of 135 days sooner.

From Q3 2021 to Q3 2022, ControlCheck has tracked 49,878,123 medication transactions.

For the fourth quarter in a row, propofol has led in variance decrease with a 10.6% decrease in cases. Propofol has been suffering shortages since April 2020.

Fentanyl continues to be the drug involved in the most variances and has led in variance increase with a 4.8% increase across the last quarter.

Download the latest information about our suite of medication intelligence products by using the button below.

Download the latest information about our suite of medication intelligence products by using the button below.